Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampicin induction of tamoxifen metabolism
NL-OMON23575Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of rifampicin and tamoxifen in breast cancer (2 arms), sponsored by Erasmus MC. Planned start Feb 2011; status: not yet recruiting.
02
Drugs
rifampicintamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON23575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23575.